Limitation of Myocardial Infarct Size. Present Status

Overview

Journal Drugs

Specialty Pharmacology

Date 1983 May 1

PMID 6134608

Citations 3

Authors

S Yusuf

P Sleight

Affiliations

Soon will be listed here.

Citing Articles

Methodological guidelines to estimate population-based health indicators using linked data and/or machine learning techniques.

Haneef R, Tijhuis M, Thiebaut R, Majek O, Pristas I, Tolonen H Arch Public Health. 2022; 80(1):9.

PMID: 34983651 PMC: 8725299. DOI: 10.1186/s13690-021-00770-6.

Reporting, updating, and correcting systematic reviews of the effects of health care.

Chalmers I, Haynes B BMJ. 1994; 309(6958):862-5.

PMID: 7950620 PMC: 2541052. DOI: 10.1136/bmj.309.6958.862.

Sudden cardiac death and the potential role of beta-adrenoceptor-blocking drugs.

Rajman I, Kendall M Postgrad Med J. 1993; 69(818):903-11.

PMID: 7907178 PMC: 2400014. DOI: 10.1136/pgmj.69.818.903.

References

HEIKINHEIMO R, Ahrenberg P, HONKAPOHJA H, IISALO E, KALLIO V, Konttinen Y . Fibrinolytic treatment in acute myocardial infarction. Acta Med Scand. 1971; 189(1-2):7-13. DOI: 10.1111/j.0954-6820.1971.tb04333.x. View

BENDA L, Haider M, Ambrosch F . [Results of the Austrian myocardial infarction study on the effects of streptokinase (author's transl)]. Wien Klin Wochenschr. 1977; 89(23):779-83. View

Norris R, Clarke E, Sammel N, Smith W, Williams B . Protective effect of propranolol in threatened myocardial infarction. Lancet. 1978; 2(8096):907-9. DOI: 10.1016/s0140-6736(78)91628-8. View

Jurgensen J, Frederiksen J, Hansen D . Limitation of myocardial infarct size in patients less than 66 years treated with alprenolol. Br Heart J. 1981; 45(5):583-8. PMC: 482568. DOI: 10.1136/hrt.45.5.583. View

Selwyn A, Ogunro E, Shillingford J . Natural history and evaluation of ST segment changes and MB CK release in acute myocardial infarction. Br Heart J. 1977; 39(9):988-94. PMC: 483358. DOI: 10.1136/hrt.39.9.988. View

Evemy K, PENTECOST B . Intravenous and oral practolol in the acute stages of myocardial infarction. Eur J Cardiol. 1978; 7(5-6):391-8. View

Muller J, Stone P, Markis J, Braunwald E . Sounding Boards. Let's not let the genie escape from the bottle--again. N Engl J Med. 1981; 304(21):1294-6. DOI: 10.1056/NEJM198105213042112. View

Bleifeld W, Hanrath P, Mathey D . Serial CPK determinations for evaluation of size and development of acute myocardial infarction. Circulation. 1976; 53(3 Suppl):I108-11. View

Bussmann W, Passek D, Seidel W, Klepzig Jr H, Kaltenbach M . [Reduction of CK and CK-MB enzyme levels as indicators of infarct size by intravenous nitroglycerin (author's transl)]. Z Kardiol. 1980; 69(1):18-30. View

10.

Rossi P, Yusuf S, Ramsdale D, Furze L, Sleight P . Reduction of ventricular arrhythmias by early intravenous atenolol in suspected acute myocardial infarction. Br Med J (Clin Res Ed). 1983; 286(6364):506-10. PMC: 1546543. DOI: 10.1136/bmj.286.6364.506. View

11.

Gormsen J . Biochemical evaluation of standard treatment with streptokinase in acute myocardial infarction. Acta Med Scand. 1972; 191(1-2):77-85. View

12.

Henderson A, CAMPBELL R, Julian D . Effect of a highly purified hyaluronidase preparation (GL enzyme) on electrocardiographic changes in acute myocardial infarction. Lancet. 1982; 1(8277):874-6. DOI: 10.1016/s0140-6736(82)92150-x. View

13.

Thompson P, FLETCHER E, Katavatis V . Enzymatic indices of myocardial necrosis: influence on short- and long-term prognosis after myocardial infarction. Circulation. 1979; 59(1):113-9. DOI: 10.1161/01.cir.59.1.113. View

14.

BROCHIER M, RAYNAUD R, PLANIOL T, Fauchier J, GRIGUER P, Archambaud D . [Treatment by urokinase of myocardial infarction and threatened infarction. Randomised study of 120 cases]. Arch Mal Coeur Vaiss. 1975; 68(6):563-9. View

15.

Ramsdale D, Faragher E, Bennett D, Bray C, Ward C, Cruickshank J . Ischemic pain relief in patients with acute myocardial infarction by intravenous atenolol. Am Heart J. 1982; 103(4 Pt 1):459-67. DOI: 10.1016/0002-8703(82)90330-1. View

16.

Roe C, COBB F, Starmer C . The relationship between enzymatic and histologic estimates of the extent of myocardial infarction in conscious dogs with permanent coronary occlusion. Circulation. 1977; 55(3):438-49. DOI: 10.1161/01.cir.55.3.438. View

17.

Maroko P, Kjekshus J, Sobel B, Watanabe T, Covell J, ROSS Jr J . Factors influencing infarct size following experimental coronary artery occlusions. Circulation. 1971; 43(1):67-82. DOI: 10.1161/01.cir.43.1.67. View

18.

Yusuf S, Lopez R, Maddison A, Maw P, Ray N, McMillan S . Value of electrocardiogram in predicting and estimating infarct size in man. Br Heart J. 1979; 42(3):286-93. PMC: 482150. DOI: 10.1136/hrt.42.3.286. View

19.

Page D, CAULFIELD J, Kastor J, DESANCTIS R, Sanders C . Myocardial changes associated with cardiogenic shock. N Engl J Med. 1971; 285(3):133-7. DOI: 10.1056/NEJM197107152850301. View

20.

Opie L, Owen P . Effect of glucose-insulin-potassium infusions on arteriovenous differences of glucose of free fatty acids and on tissue metabolic changes in dogs with developing myocardial infarction. Am J Cardiol. 1976; 38(3):310-21. DOI: 10.1016/0002-9149(76)90173-9. View